1988
DOI: 10.1002/bod.2510090208
|View full text |Cite
|
Sign up to set email alerts
|

Influence of high‐fat meal on the absorption of a silicon — containing amide, an inhibitor of acyl — coa: Cholesterol acyltransferase, in man

Abstract: The pharmacokinetics of 3-(decyldimethylsilyl)-N-[2-(4-methylphenyl)-1- phenylethyl] propanamide (DMPP), an inhibitor of acyl-CoA: cholesterol acyltransferase, have been examined in 18 healthy male volunteers who received an oral dose of either 14C-DMPP or 3H-DMPP immediately following a high-fat meal, or 3H-DMPP in the fasting state. DMPP was poorly absorbed in the fasting subjects. Administration with a high-fat meal significantly increased the extent of absorption to 15 per cent of the dose. Simultaneous fi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1989
1989
2014
2014

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…A follow-up study of the same compound in man resulted in negligible amounts of 14 CO 2 in exhaled air (0.2% of dose) after oral dosing . However, in a later study, tritium-labeled DMPP was orally administered to human volunteers; most of the material (92% of dose) was excreted unchanged, but the major urinary metabolite (4% of dose) was isolated and identified, and the pathway involved was reported to be “oxidation and loss of the decyl side chain to give the silanol”. , Thus, Si–C cleavage is prominent in metabolism of this compound in humans.…”
Section: Degradation Of Organosiloxanesmentioning
confidence: 99%
“…A follow-up study of the same compound in man resulted in negligible amounts of 14 CO 2 in exhaled air (0.2% of dose) after oral dosing . However, in a later study, tritium-labeled DMPP was orally administered to human volunteers; most of the material (92% of dose) was excreted unchanged, but the major urinary metabolite (4% of dose) was isolated and identified, and the pathway involved was reported to be “oxidation and loss of the decyl side chain to give the silanol”. , Thus, Si–C cleavage is prominent in metabolism of this compound in humans.…”
Section: Degradation Of Organosiloxanesmentioning
confidence: 99%